CPT code 88112 represents selective cellular enhancement in cytopathology, commonly implemented through liquid-based slide preparation methods that collect and preserve cells for diagnostic evaluation. This code is relevant nationally as laboratories and outpatient pathology services adopt liquid-based techniques to improve specimen adequacy, reduce repeat collections, and support more reliable cytologic interpretation. Payers across the market evaluate coverage and payment for this processing step as part of broader cytology and pathology benefit policies.

Key payers covered in this analysis include Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. Readers will find a concise overview of clinical context for 88112, the typical sites of service where the procedure is performed, and the operational role of liquid-based cytology in specimen handling. The publication summarizes benchmarking and reimbursement considerations, highlights policy and coding updates that affect billing for cytopathology specimen preparation, and outlines practical documentation and coding touchpoints relevant to providers and billing staff.

This national-level briefing is designed to help laboratory managers, pathologists, and billing professionals understand where 88112 fits in clinical workflows and payer policy, and what elements to review when aligning coding, documentation, and claims processes.